Finance

Lists
Why is BOI up २.०५%?
Dive Deeper
BOI:EPA
Boiron USA
€ १९.९०
+२.०५%
(+०.४०) 1D
नोभेम्बर ६, १७:३५:११ GMT+१  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BOI...
Open
€ १९.९०
High
€ १९.९०
Low
€ १९.२०
Mkt. cap
३५.०४ करोड
Avg. vol.
४.९५ हजार
Volume
४.२५ हजार
P/E ratio
१३.१९
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
Open
€ १९.९०
High
€ १९.९०
Low
€ १९.२०
Mkt. cap
३५.०४ करोड
Avg. vol.
४.९५ हजार
Volume
४.२५ हजार
P/E ratio
१३.१९
52-wk high
€ ३२.२५
52-wk low
€ १६.९०
EPS
€ १.५१
Shares outstanding
१.७५ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
१० घण्टा पहिले
Tech stocks are now cheaper than the S&P 500 for the first time since 2017 — here's what history says comes next: Chart of the Day
Bloomberg.com
Bloomberg.com
·
१ दिन पहिले
Anatomy of a Selloff: Sudden Chain Reaction Rattles Wall Street
Fox Business
Fox Business
·
१ दिन पहिले
Nasdaq rallies as chip stocks recover from brutal losses
Investor's Business Daily
Investor's Business Daily
·
१ घण्टा पहिले
3 Titans Hold In Damaged Market; Berkshire Doubles Stock Buyback
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA
CEO-
Employees२.६२ हजार
Founded१९३२ जुन ७
Headquarters-
SectorHealth Care
Industry-
Websiteboiron.fr
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१२.७७ करोड
१२.७७ करोड
१२.०२ करोड
१२.०२ करोड
Cost of goods sold
३.५४ करोड
३.५४ करोड
३.३५ करोड
३.३५ करोड
Cost of revenue
३.५४ करोड
३.५४ करोड
३.३५ करोड
३.३५ करोड
Research and development expenses
१५.६० लाख
१५.६० लाख
१४.४० लाख
१४.४० लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७.९३ करोड
७.९३ करोड
८.०० करोड
८.०० करोड
Operating expense
७.७५ करोड
७.७५ करोड
८.१९ करोड
८.१९ करोड
Total operating expenses
११.२९ करोड
११.२९ करोड
११.५४ करोड
११.५४ करोड
Operating income
१.४८ करोड
१.४८ करोड
४७.५५ लाख
४७.५५ लाख
Other non operating income
-११.२८ लाख
-११.२८ लाख
-२२.९१ लाख
-२२.९१ लाख
EBT including unusual items
१.३८ करोड
१.३८ करोड
४०.२० लाख
४०.२० लाख
EBT excluding unusual items
१.३२ करोड
१.३२ करोड
२७.५२ लाख
२७.५२ लाख
Income tax expense
३१.७६ लाख
३१.७६ लाख
१५.६४ लाख
१५.६४ लाख
Effective tax rate
२२.९९%
२२.९९%
३८.९०%
३८.९०%
Other operating expenses
-३३.०४ लाख
-३३.०४ लाख
४.८८ लाख
४.८८ लाख
Net income
१.०६ करोड
१.०६ करोड
२४.५५ लाख
२४.५५ लाख
Net profit margin
८.३३%
८.३३%
२.०४%
२.०४%
Earnings per share
-
-
-
-
Interest and investment income
६.५३ लाख
६.५३ लाख
६.३६ लाख
६.३६ लाख
Interest expense
-३.३५ लाख
-३.३५ लाख
-४.१० लाख
-४.१० लाख
Net interest expenses
३.१८ लाख
३.१८ लाख
२.२६ लाख
२.२६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
१.८१ करोड
१.८१ करोड
१.१२ करोड
१.१२ करोड
Gain or loss from assets sale
-४.४६ लाख
-४.४६ लाख
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू